Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPROACH-ACS-AF
2015-005566-33Phase 4Completed
- Sponsor
- LMU Klinikum
- Start
- Feb 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of apixaban, phenprocoumon, clopidogrel and aspirin in acute coronary syndrome (ACS) and Atrial fibrillation (AFib) (2 arms), sponsored by LMU Klinikum. Primary endpoint: Bleeding events. Started Feb 2016; status: completed.
02
Drugs
apixabanphenprocoumonclopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2015-005566-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005566-33.